#RemeOs

Thiard News@F4F

@newsen.bsky.social

1 day ago

Bioretec Ltd Unveils Its 2025 Financial Results and Annual Report with Recent Innovations Bioretec Ltd has published its 2025 Financial Statements and Annual Report, highlighting innovative biodegradable implant technologies in orthopedic care.

Bioretec Ltd Unveils Its 2025 Financial Results and Annual Report with Recent Innovations #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

1 day ago

Bioretec Ltd Unveils Its Financial Statements and Annual Report for 2025 Bioretec Ltd has released its Financial Statements and Annual Report for the year 2025, showcasing innovations in orthopedic technologies and growth in the market.

Bioretec Ltd Unveils Its Financial Statements and Annual Report for 2025 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 days ago

Bioretec Ltd to Launch Major Rights Issue Aiming for Financial Growth Bioretec Ltd announces plans for a significant rights issue targeting EUR 5 to 15 million to bolster its financial position and growth ambitions.

Bioretec Ltd to Launch Major Rights Issue Aiming for Financial Growth #Finland #Helsinki #Bioretec_Ltd #RemeOs #Stephen_Industries

Thiard News@F4F

@newsen.bsky.social

4 days ago

Bioretec Ltd to Launch Major Rights Issue to Strengthen Financial Position Bioretec Ltd is set to initiate a significant rights issue aimed at raising between EUR 5 million and EUR 15 million to bolster its financial stability and support its business growth plans.

Bioretec Ltd to Launch Major Rights Issue to Strengthen Financial Position #Bioretec #Finland #Helsinki #RemeOs #Stephen_Industries

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec Ltd: Upcoming Rights Issue to Strengthen Capital Base and Fund New Strategy Bioretec Ltd is considering a rights issue to bolster its financial foundation, potentially raising around EUR 15 million. This move supports its updated strategy.

Bioretec Ltd: Upcoming Rights Issue to Strengthen Capital Base and Fund New Strategy #Finland #Tampere #Bioretec_Ltd #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec Ltd Considers Rights Issue to Strengthen Capital and Support New Strategy Bioretec Ltd's Board is evaluating a potential rights issue to enhance capital resources as it pursues a new strategy aimed at growth.

Bioretec Ltd Considers Rights Issue to Strengthen Capital and Support New Strategy #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec's Financial Transformation: A Year of Strategic Renewal and Growth In 2025, Bioretec embarked on a transformative journey to restructure and enhance its business model, focusing on core technologies and expanding market presence.

Bioretec's Financial Transformation: A Year of Strategic Renewal and Growth #Bioretec #Finland #Tampere #Growth_Strategy #RemeOs

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec's Financial Year 2025: A Focused Approach to Rebuilding and Growth Bioretec Ltd reflects on a transformative 2025, focusing on rebuilding and aligning its strategies for sustainable growth and market expansion.

Bioretec's Financial Year 2025: A Focused Approach to Rebuilding and Growth #Bioretec #RemeOs #absorbable_implants

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec's Transition to Absorbable Orthopedic Implants and TPT Status Bioretec Ltd has achieved Transitional Pass-Through Payment status for its RemeOs Trauma Screw, revolutionizing absorbable orthopedic implants.

Bioretec's Transition to Absorbable Orthopedic Implants and TPT Status #Bioretec #Trauma_Screw #Finland #Tampere #RemeOs

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec Receives Transitional Pass-Through Payment for RemeOs Trauma Screw Bioretec Ltd has been awarded TPT status for its RemeOs Trauma Screw, enhancing access to innovative orthopedic technology and optimizing patient care.

Bioretec Receives Transitional Pass-Through Payment for RemeOs Trauma Screw #Bioretec #Finland #Tampere #RemeOs #TPT_Status

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec Ltd Unveils Financial Reporting Schedule and Annual General Meeting Details for 2026 Bioretec Ltd has announced its schedule for financial reporting in 2026 along with important details about its Annual General Meeting planned for May.

Bioretec Ltd Unveils Financial Reporting Schedule and Annual General Meeting Details for 2026 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec Ltd Unveils Financial Reporting Schedule and AGM for 2026 Bioretec Ltd outlines key dates for its financial reports and Annual General Meeting in 2026, highlighting advancements in orthopedic care.

Bioretec Ltd Unveils Financial Reporting Schedule and AGM for 2026 #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec's Bold Strategic Overhaul: Paving the Way to 2028 Success Bioretec Ltd unveils its updated strategy for 2026-2028, targeting sales growth and innovation with ambitious financial goals to shape the future of orthopedic implants.

Bioretec's Bold Strategic Overhaul: Paving the Way to 2028 Success #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Concludes Change Negotiations to Enhance Competitiveness and Profitability Bioretec announces the conclusion of change negotiations aimed at streamlining operations, impacting staff and promising annual cost savings in Finland.

Bioretec Concludes Change Negotiations to Enhance Competitiveness and Profitability #Bioretec #Finland #Tampere #orthopedic_care #RemeOs

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Completes Statutory Change Negotiations and Reorganization Plans Bioretec has concluded statutory negotiations to enhance its competitiveness and profitability, impacting employee roles and restructuring operations.

Bioretec Completes Statutory Change Negotiations and Reorganization Plans #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Ltd's Business Review: Strategy and Growth from January to September 2025 This article reviews Bioretec Ltd's performance and strategic adjustments in the first nine months of 2025, highlighting key developments and financial results.

Bioretec Ltd's Business Review: Strategy and Growth from January to September 2025 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Ltd's Strategic Review for 2025: A Focus on Growth and Development in Orthopedic Solutions Bioretec Ltd's business review outlines its performance and future strategy from January to September 2025, highlighting significant changes in leadership and approach.

Bioretec Ltd's Strategic Review for 2025: A Focus on Growth and Development in Orthopedic Solutions #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec in Strategic Shift to Improve Efficiency and Competitiveness Bioretec Ltd is set to engage in change negotiations aimed at boosting operational efficiency and enhancing competitiveness as it restructures its functions.

Bioretec in Strategic Shift to Improve Efficiency and Competitiveness #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Ltd's Restatement of Half-Year Financials for 2025: Insights and Implications Bioretec Ltd has announced adjustments to its H1 2025 financial results, revealing significant sales and cost changes. This article explores the details.

Bioretec Ltd's Restatement of Half-Year Financials for 2025: Insights and Implications #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Announces Adjusted Financials and Sales Strategy Shift for 2025 Bioretec Ltd reveals adjusted net sales for H1 2025, addressing shortfalls and a strategic shift away from stocking distributors. Expect new financial targets soon.

Bioretec Announces Adjusted Financials and Sales Strategy Shift for 2025 #Bioretec #Finland #Tampere #RemeOs #TSB_Distribution

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec’s Revised Financial Strategy: A Shift in Commercialization Goals Bioretec Ltd has announced a withdrawal of its financial targets due to a market strategy reassessment, aiming to provide updated goals by the end of 2025.

Bioretec’s Revised Financial Strategy: A Shift in Commercialization Goals #Bioretec #Finland #Tampere #RemeOs #DrillPin

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Withdraws Financial Targets, Adjusts Commercialization Plans for DrillPin Bioretec Ltd announces significant updates to its financial goals and commercialization strategy, particularly impacting its DrillPin project, amid extended FDA timelines.

Bioretec Withdraws Financial Targets, Adjusts Commercialization Plans for DrillPin #Bioretec #Finland #Tampere #RemeOs #DrillPin

Thiard News@F4F

@newsen.bsky.social

5 months ago

Bioretec's RemeOs Screw LAG Solid Achieves Crucial CMS Approval for Enhanced Orthopedic Care Bioretec Ltd's innovative RemeOs™ Screw LAG Solid recently secured Transitional Pass-Through Payment from CMS, revolutionizing orthopedic implant care.

Bioretec's RemeOs Screw LAG Solid Achieves Crucial CMS Approval for Enhanced Orthopedic Care #Bioretec #Finland #Tampere #RemeOs #Osteopromotive

Thiard News@F4F

@newsen.bsky.social

7 months ago

Bioretec Ltd's Half-Year Report 2025 Shows Strong Backing for Future Growth Amid Rights Issue Success Bioretec Ltd reported its half-year results for 2025, showcasing a successful rights issue and promising trends in global sales, particularly in Asia.

Bioretec Ltd's Half-Year Report 2025 Shows Strong Backing for Future Growth Amid Rights Issue Success #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

7 months ago

Bioretec Ltd's Half-Year Report 2025: Promising Growth After Rights Issue Success Bioretec Ltd released its half-year report for 2025, revealing strong support for growth driven by a successful rights issue amid a strategic shift.

Bioretec Ltd's Half-Year Report 2025: Promising Growth After Rights Issue Success #Finland #Tampere #Bioretec_Ltd #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

8 months ago

Bioretec Ltd Modifies Stock Option Program Following Successful Rights Issue Completion Bioretec Ltd announces adjustments to its stock option programs after successfully completing a rights issue, ensuring equitable treatment for shareholders and option holders.

Bioretec Ltd Modifies Stock Option Program Following Successful Rights Issue Completion #Bioretec #Finland #Tampere #RemeOs #biodegradable_implants

Thiard News@F4F

@newsen.bsky.social

8 months ago

Bioretec Oy Reports Exciting Oversubscription Results from Rights Issue Bioretec Oy's recent rights issue has garnered significant interest, leading to an oversubscription that raises EUR 9.2 million. This reflects strong investor confidence.

Bioretec Oy Reports Exciting Oversubscription Results from Rights Issue #Bioretec #Finland #Tampere #Rights_Issue #RemeOs

Thiard News@F4F

@newsen.bsky.social

9 months ago

Bioretec Ltd Initiates Rights Issue with Exemption Document Release Bioretec Ltd has announced a rights issue offering new shares to existing shareholders, supported by an exemption document as of June 2025.

Bioretec Ltd Initiates Rights Issue with Exemption Document Release #Bioretec #Finland #Tampere #RemeOs #Exemption_Document

Thiard News@F4F

@newsen.bsky.social

9 months ago

Bioretec Ltd Launches Rights Issue to Enhance Shareholder Engagement and Raise Capital Bioretec Ltd has unveiled a rights issue allowing existing shareholders to subscribe to new shares, enhancing capital and strengthening shareholder ties.

Bioretec Ltd Launches Rights Issue to Enhance Shareholder Engagement and Raise Capital #Bioretec #Finland #Tampere #Rights_Issue #RemeOs

Thiard News@F4F

@newsen.bsky.social

9 months ago

Bioretec Ltd Announces €9.2 Million Rights Issue to Fuel Future Growth and Expansion Bioretec Ltd's Board has initiated a €9.2 million rights issue aimed at bolstering its capital structure and advancing the commercialization of RemeOs products.

Bioretec Ltd Announces €9.2 Million Rights Issue to Fuel Future Growth and Expansion #Bioretec #Finland #Tampere #RemeOs #Stephen_Industries